Lorcaserin Extended-Release Tablets and Recombinate recombinant
Determining the interaction of Lorcaserin Extended-Release Tablets and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Recombivax
- Lorcaserin Extended-Release Tablets-Recombivax HB
- Lorcaserin Extended-Release Tablets-Recombivax HB Adult
- Lorcaserin Extended-Release Tablets-Recombivax HB Dialysis Formulation
- Lorcaserin Extended-Release Tablets-Recombivax HB Pediatric/Adolescent
- Lorcaserin Extended-Release Tablets-Recort Plus
- Recombinate recombinant-Lorcaserin Hydrochloride
- Recombinate recombinant-Lorcaserin Tablets
- Recombinate recombinant-Lorcet
- Recombinate recombinant-Lorcet Plus
- Recombinate recombinant-Lorcet Tablets
- Recombinate recombinant-Lorlatinib